Retinal Pigment Epithelial Tear After Intravitreal Ranibizumab (Lucentis®) for Retinal Angiomatous Proliferation (RAP) Associated with Pigment Epithelial Detachment

被引:0
|
作者
Pece, Alfredo [1 ]
Isola, Vincenzo [1 ]
Milani, Paolo [2 ]
机构
[1] Osped Vizzolo Predabissi, Milan, Italy
[2] Osped Fatebenefratelli Oftalm, Milan, Italy
关键词
age-related macular degeneration; RAP; Lucentis; (R); RPE tear;
D O I
10.1080/08820530903124276
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To report a case of retinal pigment epithelial tear after intravitreal injection of ranibizumab (Lucentis (R)) for retinal angiomatous proliferation (RAP). Methods: Interventional case report. Results: An 81-year-old woman was treated with intravitreal ranibizumab for stage-II RAP with retinal pigment epithelial (RPE) detachment. Ten days after this antiangiogenic therapy a RPE tear was detected, though no change in visual acuity occurred. Conclusion: RPE tear may be a complication of intravitreal anti-VEGF therapy with ranibizumab. The presence of a vascularized RPE detachment increases the risk and must be considered when using these new intravitreal injections.
引用
收藏
页码:210 / 213
页数:4
相关论文
共 50 条
  • [1] Retinal Pigment Epithelial Tear After Intravitreal Ranibizumab Treatment for Retinal Angiomatous Proliferation
    Cho, Han Joo
    Kim, Hyoung Seok
    Yoo, Seul Gi
    Han, Jung Il
    Lew, Young Ju
    Cho, Sung Won
    Lee, Tae Gon
    Kim, Jong Woo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 160 (05) : 1000 - 1005
  • [2] Retinal pigment epithelial tear after intravitreal ranibizumab
    Bakri, Sophie J.
    Kitzmann, Anna S.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (03) : 505 - 507
  • [3] Retinal pigment epithelial tear after ranibizumab therapy for subfoveal fibrovascular pigment epithelial detachment
    Chan, C. K.
    Lin, S. G.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (04) : 674 - 676
  • [4] Systemic bevacizumab for retinal angiomatous proliferation associated with retinal pigment epithelial detachment
    Abi-Ayad, N.
    Mauget-Faysse, M.
    Amara-Allieu, S.
    Ardisson, P.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (06) : 987 - 991
  • [5] Intravitreal ranibizumab (Lucentis®) in the treatment of retinal angiomatous proliferation (RAP)
    Lazaros Konstantinidis
    Evangelia Mameletzi
    Irmela Mantel
    Jean-Antoine Pournaras
    Leonidas Zografos
    Aude Ambresin
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247
  • [6] Retinal angiomatous proliferation complicated by pigment epithelial tear following intravitreal bevacizumab treatment
    Forooghian, Farzin
    Cukras, Catherine
    Chew, Emily Y.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2008, 43 (02): : 246 - 248
  • [7] Bimonthly half-dose ranibizumab in large pigment epithelial detachment and retinal angiomatous proliferation with high risk of retinal pigment epithelium tear: a case report
    Mones, Jordi
    Biarnes, Marc
    Badal, Josep
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 1089 - 1092
  • [8] Intravitreal Anti-Vascular Endothelial Growth Factor for Retinal Pigment Epithelial Tear in Retinal Angiomatous Proliferation
    Hwang, Hyun Ji
    Chang, Young Suk
    Kim, Jong Woo
    Lee, Tae Gon
    Kim, Chul Gu
    Cho, Sung Won
    Lee, Dong Won
    Han, Jung Il
    Kim, Jae Hui
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (01): : 71 - 79
  • [9] Retinal pigment epithelial tear after intravitreal ranibizumab for subfoveal CNV secondary to AMD
    Apte R.S.
    International Ophthalmology, 2007, 27 (1) : 59 - 61
  • [10] Retinal pigment epithelial tear after intravitreal injection of triamcinolone acetonide for neovascular pigment epithelial detachment: a mechanical explanation
    Fasolino, Giuseppe
    Bamonte, Giulio
    Patelli, Fabio
    Centola, Matteo
    Petroni, Sergio
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (05): : 575 - 576